Forschungsverbund Berlin E.V.;The Government of the United States of America as represented by the Secretary of the Department of
发明人:
Marvin C. Gershengorn,Susanne Neumann,Bruce M. Raaka,Craig J. Thomas,James Inglese,Noel T. Southall,Steven Titus,Wei Zheng,Wenwei Huang,Gerd Krause,Gunnar Kleinau
申请号：
US13897330
公开号：
US20130251631A1
申请日:
2013.05.17
申请国别(地区):
US
年份:
2013
代理人:
摘要：
Disclosed are oxo-hydroquinazolines that are useful as selective TSHR agonists. The compounds may be used for detecting or treating thyroid cancer, or treating a bone degenerative disorder.
